Ultrasound nanodroplets (
NDs) have been reported as a promising nanocarrier for
siRNA delivery depending on its unique strengths of sonoporation. Presently, common means for
NDs-mediated
siRNA delivery is through electrostatic interaction, but challenges like cationic toxicity still exist. In this study, we demonstrated a novel strategy to construct negatively charged and ultrasound (US)-responsive
O-carboxymethyl chitosan (O-CMS)
NDs as a
siRNA targeted delivery system through three-way junction of bacteriophage phi29 DNA packaging motor (3WJ-pRNA) nanotechnology. 39nt A10-3.2 aptamer targeting prostate specific membrane
antigen (PSMA) and 21nt
siRNA against
cationic amino acid transporter 1 (siCAT-1) were annealed to 3WJ-pRNA scaffold via complementation with an extended sequence. The
cholesterol molecule attached to one branch facilitates the 3WJ-pRNA nanoparticles anchoring onto
NDs. The desired O-CMS
NDs with
siRNA-loading and
RNA-aptamer modification (
A10-3.2/siCAT-1/3WJ-
NDs) were successfully prepared, which were with spherical shapes, core-shell structures and uniform in sizes (198 nm with PDI 0.3). As a main proportion of shell, O-CMC showed a certain anti-
tumor effects. In vitro studies demonstrated that
A10-3.2/siCAT-1/3WJ-
NDs exhibited good contrast-enhanced US imaging, buffering capacity and high bio-safety, were able to deliver siCAT-1 to PSMA-overexpressed
prostate cancer cells under US irradiation, thus silence the CAT-1 expression, and consequently suppressing 22RV1 cell proliferation and migration. Taken overall, our findings provide a promising strategy to develop negatively charged and US-responsive
NDs for
tumor-targeted
siRNA delivery.